Lucid Capital Markets Rates SS Innovations Stock as 'Buy' with $7 Target
Lucid Capital Markets initiates SS Innovations stock with buy rating
Investing Australia
Image: Investing Australia
Lucid Capital Markets has initiated coverage on SS Innovations International (NASDAQ:SSII) with a 'Buy' rating and a price target of $7.00, indicating substantial upside from its current price of $4.01. The company's Mantra 3 robotic surgical system is gaining traction, having completed 10,500 procedures across multiple specialties since its launch.
- 01SS Innovations' Mantra 3 robotic surgical system is priced at approximately half that of competitors like the Intuitive Surgical da Vinci robot.
- 02The company has achieved 194 robotic installs and completed 10,500 procedures across 9 specialties since launching the system.
- 03SS Innovations reported revenue of $48.5 million, with a 119% growth over the past year, although it remains unprofitable.
- 04The company has received regulatory approvals for its surgical system in Colombia, Oman, Sri Lanka, and Kenya, aiding its international expansion.
- 05A recent private placement raised approximately $18.6 million, with significant investments from company insiders.
Advertisement
In-Article Ad
Lucid Capital Markets has initiated coverage of SS Innovations International (NASDAQ:SSII) with a 'Buy' rating and a price target of $7.00, which suggests considerable upside from the current stock price of $4.01. The firm emphasized the potential of the company's Mantra 3 robotic surgical system, which is priced at about half the cost of the Intuitive Surgical da Vinci robot. Since its launch at the end of 2023, the system has seen 194 robotic installs and 10,500 cumulative procedures across 9 specialties. Despite a 35% decline in stock price over the past six months, the company reported revenues of $48.5 million, marking a 119% increase in the last year, although it remains unprofitable. Furthermore, SS Innovations has secured regulatory approvals in multiple countries, including Colombia and Kenya, which is crucial for its international growth. The company also completed a private placement that raised around $18.6 million, with notable investments from its insiders, including $2.0 million from both Chairman and CEO Dr. Sudhir Srivastava and Vice-Chairman Dr. Frederic H. Moll.
Advertisement
In-Article Ad
The developments at SS Innovations could lead to increased job opportunities and advancements in surgical technology, particularly in regions where the robotic system is introduced.
Advertisement
In-Article Ad
Reader Poll
What do you think about the potential of SS Innovations' Mantra 3 system?
Connecting to poll...
Read the original article
Visit the source for the complete story.